G755-0173 Screening compound: 3-bromo-N-{5-[({4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methyl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide

G755-0173 Screening compound: 3-bromo-N-{5-[({4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methyl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide
G755-0173 Screening compound: 3-bromo-N-{5-[({4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methyl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G755-0173
3-bromo-N-{5-[({4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methyl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G755-0173

Molecular Formula

C18H12BrN5O2S2 (C18 H12 BrN5 O2 S2)

Compound Name

3-bromo-N-{5-[({4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methyl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide

IUPAC name

3-bromo-N-{5-[({4-oxo-4H-pyrido[12-a]pyrimidin-2-yl}methyl)sulfanyl]-134-thiadiazol-2-yl}benzamide

SMILES

O=C(c1cccc(Br)c1)Nc1nnc(SCC(N=C2N3C=CC=C2)=CC3=O)s1

InChI

InChI=1S/C18H12BrN5O2S2/c19-12-5-3-4-11(8-12)16(26)21-17-22-23-18(28-17)27-10-13-9-15(25)24-7-2-1-6-14(24)20-13/h1-9H,10H2,(H,21,22,26)

InChI Key

JPUCPWBJEPALBF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27155788

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.36

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.833

Distribution Coefficient, logD

3.561

Water Solubility, LogSw

-4.16

Polar Surface Area

71.951

Acid Dissociation Constant (pKa)

7.46

Base Dissociation Constant (pKb)

2.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.60

G755-0173 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G755-0173 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G755-0173?
Check Price and Availability of G755-0173, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G755-0173 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G755-0173
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G755-0173
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G755-0173 available by request